Clinical Trials
261 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
L-Nutra Inc
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
PANO
Dublin City University
Pemb-HT
University Health Network, Toronto
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
DCE-MRI
University Hospital, Ghent
PITHAC
Centre Hospitalier Universitaire Vaudois
Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery
University of British Columbia
Family History Study on Cancer Risk
Kaiser Permanente
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
BENITA
Universitätsklinikum Hamburg-Eppendorf
Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
Peking Union Medical College Hospital
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Peking Union Medical College Hospital
NEO
University Health Network, Toronto
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
University Health Network, Toronto
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Guangxi Medical University
OPTI-DOSE
University Medical Center Groningen
Sirius in Gynaecological Laparoscopic Surgery
Precision Robotics (Hong Kong) Limited
MIRRORS-RCTP
Royal Surrey County Hospital NHS Foundation Trust
MITO-8
National Cancer Institute, Naples
AL3818
Advenchen Laboratories, LLC
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
Loyola University
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Chongqing Precision Biotech Co., Ltd
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Chongqing Precision Biotech Co., Ltd
BEACON
Peter MacCallum Cancer Centre, Australia
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
CureLab Oncology
A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.
Precision Robotics (Hong Kong) Limited
A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Liaoning Cancer Hospital & Institute
Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer
Second Affiliated Hospital of Guangzhou Medical University
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
SELENIUM
Seoul National University Hospital
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage III/IV BRCA Wild-type Ovarian Cancer
Ruijin Hospital
AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer
Hunan Cancer Hospital
The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab
Fudan University
Individualized Precision Treatment Based on Ovarian Cancer Organoid Model
The First Affiliated Hospital of Xiamen University
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Shanghai Yunying Medical Technology
NKG2D CAR-NK & Ovarian Cancer
Hangzhou Cheetah Cell Therapeutics Co., Ltd
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
National Cancer Institute, Naples
MITO-7
National Cancer Institute, Naples
MITO16/MANGO-2
National Cancer Institute, Naples
MITO16MANGO2b
National Cancer Institute, Naples
MITO28MaNGOov4
National Cancer Institute, Naples
MITO 31
National Cancer Institute, Naples